Med Tech Talks Podcast
Robert Klupacs, CEO of the Bionics Institute, a world leader in medical device development, talks to leaders, investors, researchers and entrepreneurs in the med tech industry. He delves into their story, who and what motivated them along the way, and their advice to those following a similar path. He also explores the concept of innovation, and what it will take to improve the translation of innovation into commercialisation to change the lives of people living with challenging medical conditions.
Med Tech Talks Podcast
Insights into innovation investment from venture capitalist Dr Chris Smith
•
Bionics Institute
•
Episode 30
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Chris Smith, a partner at Brandon Capital - Australasia's leading life science venture capital firm.
Chris has extensive experience in the global biotech industry. With a PhD in immunology and an MBA specialising in innovation and entrepreneurship from the University of Cambridge; he has also previously been a business development manager with CSL; and is currently a Director of Aravax, Denteric, Ena Respiratory, MycRx, Q-Sera and Axelia Oncology, just to name a few.
In this episode, you will hear more about:
- Tips for pitching to investors and building a relationship with venture capital firms
- Demystifying the role of a VC in research and development
- Brandon Capital’s incubator approach to risk and investing in early-stage innovations.
Visit the Brandon Capital website
Updated version 05/08/22
